Cargando…
Crosstalk between the liver and heart: revisited for prevention and treatment
Autores principales: | Tanaka, Atsushi, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754941/ https://www.ncbi.nlm.nih.gov/pubmed/33001582 http://dx.doi.org/10.1002/ehf2.13034 |
Ejemplares similares
-
In‐hospital therapy for worsening heart failure: black box or sweet spot?
por: Tanaka, Atsushi, et al.
Publicado: (2021) -
So‐far overlooked HFpEF patients with normal natriuretic peptide level need more evidence
por: Tanaka, Atsushi, et al.
Publicado: (2022) -
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
por: Tanaka, Atsushi, et al.
Publicado: (2020) -
Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
por: Tanaka, Atsushi, et al.
Publicado: (2018) -
Pellgra revisited
por: Gupta, Sunil Kumar, et al.
Publicado: (2014)